The investigators identified 64,000+ adults aged 45 or older with overweight or obesity and atherosclerotic cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) but no diabetes diagnosis, who initiated semaglutide or tirzepatide between May 2022 and January 2025
The FDA's 503B compounding enforcement actions, which escalated through 2025, have placed significant pressure on this model
Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization
Other notable TruBrain products In addition to their signature shots, TruBrain offers a handful of other products, some of which are nootropics
See, the most common mistake people make is diving into rigid, cookie-cutter plans that feel more like a straitjacket than a lifestyle change
Grifoni, A